Covaxin has interim efficacy of 81%: Bharat Biotech

March 03, 2021 17:47

Covaxin has demonstrated an interim vaccine efficacy of 81 per cent in its Phase 3 clinical trial, says Bharat Biotech.

The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with Indian Council of Medical Research, it said.

More details awaited. -- ANI

« Back to LIVE

TOP STORIES

Rohit breaks silence on losing IPL captaincy

Rohit is a tough cookie and the genial exterior concealed his real feelings as he said that playing under Pandya is no different from playing under any other captain.

IPL PIX: Reddy, Head power SRH to 201/3 VS Royals

IMAGES from the IPL match between Sunrisers Hyderabad and Rajasthan Royals played in Hyderabad on Thursday

Sakshi slams BJP: 'Daughters of country lost, Brij Bhushan wins'

Sakshi Malik expresses anguish at Brij Bhushan's son getting BJP ticket for Lok Sabha polls

RBI says 97.76% of Rs 2000 currency notes returned

The Reserve Bank of India (RBI) on Thursday said 97.76 per cent of the Rs 2000 denomination banknotes have returned to the banking system, and only Rs 7,961 crore worth of the withdrawn notes are still with the public. On May 19, 2023,...

Cognizant March quarter net profit down 5.8% to $546 million

Nasdaq-listed IT services company Cognizant has reported a 5.8 per cent year-on-year decline in consolidated net profit for the March quarter to $546 million. The company in a release said its revenue guidance for the full year 2024 is...